# Tigecycline for Treatment of Rapidly Growing Mycobacteria

> **NCT00600600** · PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center at Tyler** · enrollment: 8 (actual)

## Conditions studied

- Mycobacterium Abscessus Lung Disease
- Rapidly Growing Mycobacterial Lung Disease

## Interventions

- **DRUG:** Tigecycline

## Key facts

- **NCT ID:** NCT00600600
- **Lead sponsor:** The University of Texas Health Science Center at Tyler
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00600600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00600600, "Tigecycline for Treatment of Rapidly Growing Mycobacteria". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00600600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*